Source: Annual Congress 2006 - Evaluation of drugs for lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Hemrmanowicz-Salamon, J. Mazurek, T. Przybylowski, R. Chazan (Warsaw, Portugal). Exhaled nitric oxide (FENO) in the assessment of the safety of allergen immunotherapy (SIT) in asthma patients. Eur Respir J 2006; 28: Suppl. 50, 1247

Member's Comments

No comment yet.

Related content which might interest you: Exhaled nitric oxide (FENO) in patients with rhinitis and asthma-like symptoms Source: Eur Respir J 2005; 26: Suppl. 49, 280s Year: 2005 The clinical utility of exhaled nitric oxide (eNO) in asthma, the first 1,000 patients Source: Eur Respir J 2004; 24: Suppl. 48, 304s Year: 2004 Stability of exhaled nitric oxide (FENO) in patients with severe, steroid-dependent asthma Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement Year: 2008 Dynamics of the nitric oxide metabolites in the exhaled breath condensate (EBC) in atopic asthma (BA) children receiving various treatment options Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Exhaled nitric oxide (FeNO) in relation to exacerbation of childhood asthma Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Exhaled nitric oxide in specific challenge tests to assess occupational asthma Source: Eur Respir J 2002; 20: 1532-1537 Year: 2002 Diagnosing asthma using exhaled nitric oxide (eNO) measurements Source: Annual Congress 2003 - Recognition, management and assessment of asthma including severe asthma Year: 2003 Fractional exhaled nitric oxide (FeNO) could be a good predictor for the effectiveness of inhaled corticosteroid (ICS) in patients with COPD Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases Year: 2009 Exhaled nitric oxide (eNO) levels in asthmatic children: relation to atopy and airway responsiveness (AHR) Source: Eur Respir J 2004; 24: Suppl. 48, 271s Year: 2004 Relationship between exhaled nitric oxide (eNO), atopy and asthma in children. ISAAC-clermont-ferrand Source: Eur Respir J 2001; 18: Suppl. 33, 38s Year: 2001 Optimising inhaled corticosteroid (ICS) dose using exhaled nitric oxide (eNO) measurements Source: Eur Respir J 2003; 22: Suppl. 45, 34s Year: 2003 Clinical usefulness of fractional exhaled nitric oxide (FeNO) as a marker of long-term asthma control Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009 Exhaled nitric oxide (FeNO) and serum IgE total (sIgE) are related to the type of sensitization in children with allergic rhinitis Source: Annual Congress 2008 - Exercise-induced asthma, acute severe asthma and allergic rhinitis in children Year: 2008 Exhaled nitric oxide (eNO): an early indicator of asthma relapse in children Source: Eur Respir J 2005; 26: Suppl. 49, 42s Year: 2005 The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma Source: Eur Respir J 2010; 35: 1221-1227 Year: 2010 Exhaled nitric oxide, nitrite/nitrate levels, allergy, rhinitis and asthma in the EGEA study Source: Eur Respir J 2014; 44: 351-360 Year: 2014 Fractional exhaled nitric oxide (FeNO) for an early diagnosis of asthma Source: Eur Respir J 2006; 28: Suppl. 50, 677s Year: 2006 Is exhaled nitric oxide (eNO) an indipendent outcome measure in chronic stable asthma? Source: Eur Respir J 2002; 20: Suppl. 38, 196s Year: 2002 Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016